Why This Comparison Matters
Fraxel Dual and UltraPulse sit in the same skin resurfacing category but take different approaches. Fraxel Dual (Solta Medical) uses Dual-Wavelength Non-Ablative Fractional Laser (1550nm + 1927nm) while UltraPulse (Lumenis) uses Fractional CO2 Laser with DeepFX and ActiveFX handpieces. Both received FDA clearance (2008 and 2008 respectively) and both are actively sold in the US market. The decision between them is rarely about which is objectively better. It's about which fits your specific practice.
Physicians end up comparing these two devices when they're shopping in the $95,000-$145,000 to $130,000-$200,000 price range and want a category leader. Both devices are commonly recommended by sales reps from competing manufacturers, which means physicians often hear inflated claims about one and dismissive claims about the other. This comparison strips out the marketing and looks at pricing, mechanism, evidence, and practice fit side by side.
The Verdict
Choose Fraxel Dual if your practice prioritizes Solta Medical's ecosystem, brand recognition, or specific clinical advantages. Dermatology practices that treat melasma and photodamaged skin on mixed patient populations. Practices that value brand recognition and a deep evidence base. The pros that matter most: Longest-running brand recognition in fractional skin resurfacing; FDA-cleared for melasma, an indication few competitors hold. The biggest tradeoff to accept: Solta parent Bausch Health carries heavy debt load.
Choose UltraPulse if Lumenis's positioning fits better. Plastic surgery and academic dermatology practices with established resurfacing programs. Practices performing scar revision and surgical procedures that benefit from a powerful CO2 platform. The pros that matter most: Most powerful CO2 fractional laser on the market; Dual handpieces (DeepFX for depth, ActiveFX for surface) cover both layers. The biggest tradeoff to accept: Significant patient downtime (7-14 days).
For a practice with limited capital that needs maximum flexibility, used pricing tilts the math. Fraxel Dual used units run $35,000-$70,000; UltraPulse used units run $45,000-$90,000. For practices with strong patient flow already, the device that integrates with your existing platforms is usually the right answer even if its standalone specs are slightly weaker. For practices building a category from scratch, brand recognition and patient demand matter more than raw clinical specs. Look at which device patients are already asking for in your market before signing a contract.
Frequently Asked Questions
Which is more expensive, Fraxel Dual or UltraPulse?
Fraxel Dual runs $95,000-$145,000 new and $35,000-$70,000 used. UltraPulse runs $130,000-$200,000 new and $45,000-$90,000 used. Per-session pricing is $900-$1,800 for Fraxel Dual and $1,500-$4,000 for UltraPulse. Annual operating costs (consumables plus maintenance) typically run 5-15% of purchase price for both devices. The right financial comparison includes total cost of ownership over 5 years, not just sticker price.
Which has better clinical evidence, Fraxel Dual or UltraPulse?
Fraxel Dual clinical evidence: 100+ published studies. The most-studied fractional laser platform in the aesthetic market. UltraPulse clinical evidence: 100+ published studies. The reference standard for fractional CO2 treatment outcomes and depth control. Evidence quality is not about study count alone. Look at sample sizes, blinded evaluators, independence from manufacturer funding, and outcome durability. Older devices in the same category usually have stronger evidence because they've been studied longer.
Is Fraxel Dual or UltraPulse more popular in dermatology practices?
Both Fraxel Dual and UltraPulse are commonly used in dermatology, plastic surgery practices. Market share in any given category shifts year to year. Solta Medical and Lumenis both maintain active sales forces in the US. Ask other physicians in your specialty which platform they're using and why. Peer references in your local market matter more than national market share data.
Are there safety concerns with Fraxel Dual or UltraPulse?
Both devices are FDA cleared and have established safety profiles. Fraxel Dual has these documented concerns: Solta parent Bausch Health carries heavy debt load. UltraPulse has: Significant patient downtime (7-14 days). Physicians should monitor FDA MAUDE reports for both devices before purchase. Adverse event trends matter because they signal problems that may not appear in marketing materials. Any device with a sudden spike in MAUDE filings deserves closer scrutiny.
Can I use Fraxel Dual and UltraPulse in the same practice?
Some practices run both devices, especially when they target different patient segments or treatment areas. The downside is duplicated training, parallel consumable inventories, and potential cannibalization between platforms. The upside is broader marketing claims and the ability to switch patients between platforms if one doesn't deliver expected results. Most practices choose one and commit to mastering it rather than splitting volume.
What's the resale value comparison between Fraxel Dual and UltraPulse?
Used Fraxel Dual sells for $35,000-$70,000 on the secondary market. Used UltraPulse sells for $45,000-$90,000. Resale values depend on age, software version, applicator condition, and remaining warranty. Devices with strong installed bases hold value better. Devices with active safety signals or declining manufacturer financial health depreciate faster. Resale value should be a factor in any device purchase, especially if practice plans might change in 3-5 years.
Fraxel Dual vs UltraPulse: which is better for dermatology practices in 2026?
For dermatology practices specifically in 2026, the choice between Fraxel Dual and UltraPulse depends on three factors: existing equipment compatibility (does the new device integrate with what you already run), patient mix and treatment volume (high-volume practices typically benefit from Fraxel Dual's longest-running brand recognition in fractional skin resurfacing while lower-volume practices often prefer UltraPulse's most powerful co2 fractional laser on the market), and total cost of ownership over 5 years including consumables and maintenance. Run the side-by-side TCO analysis with realistic patient volume projections before committing to either platform.
Fraxel Dual vs UltraPulse: 2026 update on features and clinical evidence?
As of April 2026, both Fraxel Dual and UltraPulse continue commercial availability from Solta Medical and Lumenis respectively. Recent updates worth tracking: software releases, new applicator launches, expanded FDA labeling indications, and new peer-reviewed clinical evidence publications. Manufacturer financial stability also matters for long-term support and parts availability. Both manufacturers share business updates periodically that inform the long-term outlook for each device.
How do I choose between Fraxel Dual and UltraPulse for my practice?
Use a structured decision framework: list 5-7 must-have requirements specific to your patient mix and practice economics, score Fraxel Dual and UltraPulse against each requirement on a 1-5 scale, weight the requirements by importance, then sum the weighted scores. The platform that scores meaningfully higher (10%+ gap) is the right choice. If the scores are within 10%, secondary factors decide: manufacturer relationship, financing terms, training availability, and resale value. Avoid choosing based on feature breadth alone because most devices in this category have similar feature checkboxes. The differentiation is in workflow fit, treatment results, and total cost over 5 years.
Are there better alternatives to Fraxel Dual or UltraPulse in the skin resurfacing category?
In the skin resurfacing category, Fraxel Dual and UltraPulse are often the leading platforms but other alternatives may fit specific practice profiles better. Other category options include clear-brilliant, halo, lasemd-ultra. Run a 4-platform shortlist evaluation rather than a 2-platform binary because hidden alternatives sometimes outperform on the metrics that matter most to your specific practice.